Alzheimer disease: Aβ-independent processes-rethinking preclinical AD.
about
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersMolecular Mechanisms in the Pathogenesis of Alzheimer's disease and Tauopathies-Prion-Like Seeded Aggregation and PhosphorylationSuspected non-Alzheimer disease pathophysiology--concept and controversyMechanical Stress as the Common Denominator between Chronic Inflammation, Cancer, and Alzheimer's DiseaseThe role of iron-induced fibrin in the pathogenesis of Alzheimer's disease and the protective role of magnesiumRodent models of neuroinflammation for Alzheimer's diseaseInconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's diseaseSpreading of pathology in neurodegenerative diseases: a focus on human studiesThe preclinical phase of the pathological process underlying sporadic Alzheimer's diseaseWhy musical memory can be preserved in advanced Alzheimer's disease.Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration.Amyloid burden and neural function in people at risk for Alzheimer's Disease.Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer's Disease NeuropathologyAmyloid burden, neuronal function, and cognitive decline in middle-aged adults at risk for Alzheimer's diseasePART and SNAP.The evolution of preclinical Alzheimer's disease: implications for prevention trials.Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals.Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional studyMild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progressionDifferential white matter connectivity in early mild cognitive impairment according to CSF biomarkersSpatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer diseaseAmyloid accelerates tau propagation and toxicity in a model of early Alzheimer's diseaseAre AD-Typical Regions the Convergence Point of Multiple Pathologies?Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography.Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findingsDiverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's diseaseCerebrospinal fluid ratios with Aβ42 predict preclinical brain β-amyloid accumulation.White matter integrity determined with diffusion tensor imaging in older adults without dementia: influence of amyloid load and neurodegeneration.Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease.Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementia.Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults.Biomarker modeling of Alzheimer's disease.The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.Biomarker modelling of early molecular changes in Alzheimer's disease.Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition.Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals.A Novel, Multi-Target Natural Drug Candidate, Matrine, Improves Cognitive Deficits in Alzheimer's Disease Transgenic Mice by Inhibiting Aβ Aggregation and Blocking the RAGE/Aβ Axis.
P2860
Q26745508-8F61572E-E7FB-4810-AD2E-5E4FE6F3063FQ26748105-D4040B48-59E5-43E9-AAB3-1984EF7A636EQ26771270-53FB9285-4921-46C1-BDC5-37AE83BA8D10Q26781105-0365927E-02B2-4B74-AC4B-1F3008E6546CQ26859190-645E4D0B-AF86-4A07-9328-296EE2529E5BQ26864804-8FA06C99-84A7-4773-9888-652708B953A3Q27003841-F8D515CA-3994-4488-98F0-FC82588E69E2Q28082279-0797944E-DDF9-43A5-A39E-08221C7CBBD6Q28083428-F608FF6F-5B36-476A-B5ED-D961FB7D46FEQ30375294-D26C0D48-6283-4A59-9729-B2FB1E8C7DA6Q30996727-C88BB4FF-CFC3-4A76-88B2-E1819A6573A5Q33581412-39F64CC0-5BDD-4EE9-9EDC-033A060AA2AFQ33599047-E0634F58-1AAF-454B-A2C2-9C572071949EQ33741411-B42E0F32-B91C-4597-AA5C-E95FCEF6C726Q33839157-44A30569-918E-456D-9E94-A6DA053CFFBAQ33920450-81AFC965-42CA-4EE5-8D9F-FE473512F8CDQ34507153-26AEAB0F-AB30-4151-8FE7-B05DBFD5E029Q34849048-F135CBE1-7E2D-4883-B07C-BE5E52CE75C8Q34940642-69801E54-AA5F-432A-98F0-FF47C51F652DQ35073049-A705314D-BB47-4366-9A50-340F5CCDE217Q35106472-54B3F985-9F1F-435F-8272-06054A1C1852Q35116529-1985C40B-FAF1-404C-93DD-27942E04C792Q35195654-592B44B3-A1A3-40EF-B272-04DEE5F89D73Q35212180-6CE0A73C-CF83-41CD-8596-FB9965B629ECQ35216192-11D21063-753C-4905-8148-019843877FC6Q35598271-60DD9582-44E5-41BF-B56A-16C1104DC755Q36265825-A0A48615-FA26-42B1-A189-343783698F6AQ36305487-97CEC584-6C8E-4CAD-97C0-793020294DADQ36615510-E3EF1811-5360-4FD1-9F1C-9160757A62F5Q36651546-182D426D-9272-484A-9E8F-F8237D61B006Q36736127-D908BB55-7250-4D13-B92A-DD1F6465BD23Q37184248-6FE7FD88-4EB7-4D02-8C4D-B3924D2B2CC5Q37217094-8D872F33-1462-4651-A125-C8E7287B2422Q37395886-CFE0EC92-A0FF-4932-A419-8561E9910B71Q37592824-5746ECC1-C2BE-4EE0-8B07-8A3E31AD9367Q37656554-C9E15F35-09A5-4EA9-A065-BF62873C5D77Q38166669-226B41C7-EB52-458D-937B-2E5BE8A64CCFQ38697144-C489E7BA-819D-4779-922B-72A13222EC1CQ38829043-A3555286-68DF-486A-A50E-7384CC245620Q38905278-4F339CA9-8038-407B-96F3-7320028B438E
P2860
Alzheimer disease: Aβ-independent processes-rethinking preclinical AD.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alzheimer disease: Aβ-independent processes-rethinking preclinical AD.
@en
Alzheimer disease: Aβ-independent processes-rethinking preclinical AD.
@nl
type
label
Alzheimer disease: Aβ-independent processes-rethinking preclinical AD.
@en
Alzheimer disease: Aβ-independent processes-rethinking preclinical AD.
@nl
prefLabel
Alzheimer disease: Aβ-independent processes-rethinking preclinical AD.
@en
Alzheimer disease: Aβ-independent processes-rethinking preclinical AD.
@nl
P2860
P356
P1476
Alzheimer disease: Aβ-independent processes-rethinking preclinical AD.
@en
P2093
Gaël Chételat
P2860
P2888
P304
P356
10.1038/NRNEUROL.2013.21
P407
P577
2013-02-12T00:00:00Z